Leiner’s U.S. OTC Operations Face Regulatory, Competitive Obstacles

Leiner Health Products says the process of restarting its U.S. OTC operations is complicated by Dr. Reddy's Laboratories' termination of contracts to supply ingredients it needs to manufacture OTCs